{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:14:15Z","timestamp":1794964455779,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science Foundation","award":["1648822"],"award-info":[{"award-number":["1648822"]}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY025585"],"award-info":[{"award-number":["P30EY025585"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["T32 EY024236"],"award-info":[{"award-number":["T32 EY024236"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY025687"],"award-info":[{"award-number":["R01EY025687"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY032342"],"award-info":[{"award-number":["R01EY032342"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS109328"],"award-info":[{"award-number":["K23NS109328"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"crossref","award":["FG-1807-31882"],"award-info":[{"award-number":["FG-1807-31882"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"crossref","award":["FG-2108-38411"],"award-info":[{"award-number":["FG-2108-38411"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thalamic volume is associated with clinical disability in multiple sclerosis (MS) and is vulnerable to secondary neurodegeneration due to its extensive connectivity throughout the central nervous system (CNS). Using a model of autoimmune demyelination that exhibits CNS-infiltrating immune cells in both spinal cord white matter and optic nerve, we sought to evaluate neurodegenerative changes due to lesions affecting the spino- and retino-thalamic pathways. We found comparable axonal loss in spinal cord white matter and optic nerve during the acute phase of disease consistent with synaptic loss, but not neuronal cell body loss in the thalamic nuclei that receive input from these discrete pathways. Loss of spinal cord neurons or retinal ganglion cells retrograde to their respective axons was not observed until the chronic phase of disease, where optical coherence tomography (OCT) documented reduced inner retinal thickness. In patients with relapsing\u2013remitting MS without a history of optic neuritis, OCT measures of inner retinal volume correlated with retino-thalamic (lateral geniculate nucleus) and spino-thalamic (ventral posterior nucleus) volume as well as neuroperformance measures. These data suggest retinal imaging may serve as an important noninvasive predictor of neurodegeneration in MS.<\/jats:p>","DOI":"10.1186\/s40478-022-01391-y","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T11:03:57Z","timestamp":1655291037000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis"],"prefix":"10.1186","volume":"10","author":[{"given":"Gabrielle M.","family":"Mey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten S.","family":"Evonuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKenzie K.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Batoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Peachey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Anand-Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bermel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ontaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedar R.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1212-5762","authenticated-orcid":false,"given":"Tara M.","family":"DeSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"1391_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.neuro.30.051606.094313","volume":"31","author":"BD Trapp","year":"2008","unstructured":"Trapp BD, Nave KA (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247\u2013269","journal-title":"Annu Rev Neurosci"},{"key":"1391_CR2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJM200011163432001","volume":"343","author":"C Confavreux","year":"2000","unstructured":"Confavreux C, Vukusic S, Moreau T, Adeleine P (2000) Relapses and progression of disability in multiple sclerosis. N Engl J Med 343:1430\u20131438","journal-title":"N Engl J Med"},{"key":"1391_CR3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ana.25145","volume":"83","author":"A Eshaghi","year":"2018","unstructured":"Eshaghi A et al (2018) Deep gray matter volume loss drives disability worsening in multiple sclerosis. Ann Neurol 83:210\u2013222","journal-title":"Ann Neurol"},{"key":"1391_CR4","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.21423","volume":"64","author":"LK Fisniku","year":"2008","unstructured":"Fisniku LK et al (2008) Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 64:247\u2013254","journal-title":"Ann Neurol"},{"key":"1391_CR5","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1212\/01.wnl.0000435551.90824.d0","volume":"81","author":"M Filippi","year":"2013","unstructured":"Filippi M et al (2013) Gray matter damage predicts the accumulation of disability 13 years later in MS. Neurology 81:1759\u20131767","journal-title":"Neurology"},{"key":"1391_CR6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1148\/radiol.10100326","volume":"257","author":"MA Rocca","year":"2010","unstructured":"Rocca MA et al (2010) Thalamic damage and long-term progression of disability in multiple sclerosis. Radiology 257:463\u2013469","journal-title":"Radiology"},{"key":"1391_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.25743","volume":"88","author":"KR Mahajan","year":"2020","unstructured":"Mahajan KR, Nakamura K, Cohen JA, Trapp BD, Ontaneda D (2020) Intrinsic and extrinsic mechanisms of thalamic pathology in multiple sclerosis. Ann Neurol 88:81\u201392","journal-title":"Ann Neurol"},{"key":"1391_CR8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1352458519826364","volume":"26","author":"ES Sotirchos","year":"2020","unstructured":"Sotirchos ES et al (2020) Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis. Mult Scler 26:312\u2013321","journal-title":"Mult Scler"},{"key":"1391_CR9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1177\/1352458510376405","volume":"16","author":"M Calabrese","year":"2010","unstructured":"Calabrese M et al (2010) Basal ganglia and frontal\/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis. Mult Scler 16:1220\u20131228","journal-title":"Mult Scler"},{"key":"1391_CR10","first-page":"205521731982761","volume":"5","author":"I Kletenik","year":"2019","unstructured":"Kletenik I et al (2019) Subjective cognitive concern in multiple sclerosis is associated with reduced thalamic and cortical gray matter volumes. Mult Scler J Exp Transl Clin 5:2055217319827618","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"1391_CR11","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/482536","volume":"2015","author":"RE Klaren","year":"2015","unstructured":"Klaren RE et al (2015) Objectively measured physical activity is associated with brain volumetric measurements in multiple sclerosis. Behav Neurol 2015:482536","journal-title":"Behav Neurol"},{"key":"1391_CR12","volume":"68","author":"BA t Hart","year":"2021","unstructured":"t Hart BA, Luchicchi A, Schenk GJ, Killestein J, Geurts JJG (2021) Multiple sclerosis and drug discovery: A work of translation. EBioMedicine 68:103392","journal-title":"EBioMedicine"},{"key":"1391_CR13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.24487","volume":"78","author":"S Saidha","year":"2015","unstructured":"Saidha S et al (2015) Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol 78:801\u2013813","journal-title":"Ann Neurol"},{"key":"1391_CR14","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/hbm.23946","volume":"39","author":"C Alves","year":"2018","unstructured":"Alves C et al (2018) The retinal ganglion cell layer predicts normal-appearing white matter tract integrity in multiple sclerosis: a combined diffusion tensor imaging and optical coherence tomography approach. Hum Brain Mapp 39:1712\u20131720","journal-title":"Hum Brain Mapp"},{"key":"1391_CR15","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1212\/01.wnl.0000278387.15090.5a","volume":"69","author":"GF Wu","year":"2007","unstructured":"Wu GF et al (2007) Relation of vision to global and regional brain MRI in multiple sclerosis. Neurology 69:2128\u20132135","journal-title":"Neurology"},{"key":"1391_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1212\/WNL.0b013e31827deb39","volume":"80","author":"A Klistorner","year":"2013","unstructured":"Klistorner A et al (2013) Axonal loss in non\u2013optic neuritis eyes of patients with multiple sclerosis linked to delayed visual evoked potential. Neurology 80:242\u2013245","journal-title":"Neurology"},{"key":"1391_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3988\/jcn.2015.11.3.241","volume":"11","author":"YM Huang-Link","year":"2015","unstructured":"Huang-Link YM, Fredrikson M, Link H (2015) Benign multiple sclerosis is associated with reduced thinning of the retinal nerve fiber and ganglion cell layers in non-optic-neuritis eyes. J Clin Neurol (Seoul, Korea) 11:241\u2013247","journal-title":"J Clin Neurol (Seoul, Korea)"},{"key":"1391_CR18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","volume":"113","author":"JB Fisher","year":"2006","unstructured":"Fisher JB et al (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 113:324\u2013332","journal-title":"Ophthalmology"},{"key":"1391_CR19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/jnnp.55.9.747","volume":"55","author":"WI McDonald","year":"1992","unstructured":"McDonald WI, Barnes D (1992) The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry 55:747\u2013752","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1391_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12974-019-1583-4","volume":"16","author":"A Cruz-Herranz","year":"2019","unstructured":"Cruz-Herranz A et al (2019) Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis. J Neuroinflammation 16:203","journal-title":"J Neuroinflammation"},{"key":"1391_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s40478-019-0767-6","volume":"7","author":"J Jin","year":"2019","unstructured":"Jin J et al (2019) Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis. Acta Neuropathol Commun 7:125","journal-title":"Acta Neuropathol Commun"},{"key":"1391_CR22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-019-0768-5","volume":"7","author":"P Manogaran","year":"2019","unstructured":"Manogaran P et al (2019) Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis. Acta Neuropathol Commun 7:116","journal-title":"Acta Neuropathol Commun"},{"key":"1391_CR23","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.1501097","volume":"195","author":"KS Carbajal","year":"2015","unstructured":"Carbajal KS et al (2015) Th cell diversity in experimental autoimmune encephalomyelitis and multiple sclerosis. J Immunol 195:2552\u20132559","journal-title":"J Immunol"},{"key":"1391_CR24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1742-2094-10-120","volume":"10","author":"L Horstmann","year":"2013","unstructured":"Horstmann L et al (2013) Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model. J Neuroinflammation 10:120\u2013120","journal-title":"J Neuroinflammation"},{"key":"1391_CR25","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/1352458506070629","volume":"12","author":"KS Shindler","year":"2006","unstructured":"Shindler KS, Guan Y, Ventura E, Bennett J, Rostami A (2006) Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis. Mult Scler J 12:526\u2013532","journal-title":"Mult Scler J"},{"key":"1391_CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fneur.2011.00050","volume":"2","author":"TA Quinn","year":"2011","unstructured":"Quinn TA, Dutt M, Shindler KS (2011) Optic neuritis and retinal ganglion cell loss in a chronic murine model of multiple sclerosis. Front Neurol 2:50\u201350","journal-title":"Front Neurol"},{"key":"1391_CR27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/bpa.12930","volume":"31","author":"MT Sekyi","year":"2021","unstructured":"Sekyi MT et al (2021) Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis. Brain Pathol 31:312\u2013332","journal-title":"Brain Pathol"},{"key":"1391_CR28","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1177\/1352458509350470","volume":"15","author":"M Laron","year":"2009","unstructured":"Laron M et al (2009) Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials. Mult Scler 15:1431\u20131441","journal-title":"Mult Scler"},{"key":"1391_CR29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1191\/1352458503ms935rr","volume":"9","author":"B Weinstock-Guttman","year":"2003","unstructured":"Weinstock-Guttman B et al (2003) Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis. Mult Scler 9:529\u2013534","journal-title":"Mult Scler"},{"key":"1391_CR30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/bmj.4.5893.661","volume":"4","author":"AM Halliday","year":"1973","unstructured":"Halliday AM, McDonald WI, Mushin J (1973) Visual evoked response in diagnosis of multiple sclerosis. Br Med J 4:661\u2013664","journal-title":"Br Med J"},{"key":"1391_CR31","first-page":"205521732096347","volume":"6","author":"S Marenna","year":"2020","unstructured":"Marenna S et al (2020) Functional evolution of visual involvement in experimental autoimmune encephalomyelitis. Mult Scler J Exp Transl Clin 6:2055217320963474","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"1391_CR32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bpa.12762","volume":"30","author":"V Castoldi","year":"2020","unstructured":"Castoldi V et al (2020) Non-invasive visual evoked potentials to assess optic nerve involvement in the dark agouti rat model of experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Brain Pathol 30:137\u2013150","journal-title":"Brain Pathol"},{"key":"1391_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.immuni.2019.12.004","volume":"52","author":"S Werneburg","year":"2020","unstructured":"Werneburg S et al (2020) Targeted complement inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease. Immunity 52:167-182.e167","journal-title":"Immunity"},{"key":"1391_CR34","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000295995.46586.ae","volume":"69","author":"E Gordon-Lipkin","year":"2007","unstructured":"Gordon-Lipkin E et al (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology 69:1603","journal-title":"Neurology"},{"key":"1391_CR35","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archneurol.2009.230","volume":"66","author":"BM Burkholder","year":"2009","unstructured":"Burkholder BM et al (2009) Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol 66:1366\u20131372","journal-title":"Arch Neurol"},{"key":"1391_CR36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.20575","volume":"58","author":"SA Trip","year":"2005","unstructured":"Trip SA et al (2005) Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 58:383\u2013391","journal-title":"Ann Neurol"},{"key":"1391_CR37","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1177\/1352458513485147","volume":"19","author":"CJ Morgan","year":"2013","unstructured":"Morgan CJ, Ranjan A, Aban IB, Cutter GR (2013) The magnetic resonance imaging \u201crule of five\u201d: predicting the occurrence of relapse. Mult Scler 19:1760\u20131764","journal-title":"Mult Scler"},{"key":"1391_CR38","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/brain\/awq080","volume":"133","author":"AJ Green","year":"2010","unstructured":"Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133:1591\u20131601","journal-title":"Brain"},{"key":"1391_CR39","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/1352458515604905","volume":"22","author":"H Kearney","year":"2016","unstructured":"Kearney H et al (2016) Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis. Mult Scler 22:910\u2013920","journal-title":"Mult Scler"},{"key":"1391_CR40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/brain\/awy352","volume":"142","author":"D Eden","year":"2019","unstructured":"Eden D et al (2019) Spatial distribution of multiple sclerosis lesions in the cervical spinal cord. Brain 142:633\u2013646","journal-title":"Brain"},{"key":"1391_CR41","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/1352458520929192","volume":"27","author":"E Sechi","year":"2021","unstructured":"Sechi E et al (2021) Critical spinal cord lesions associate with secondary progressive motor impairment in long-standing MS: a population-based case-control study. Mult Scler 27:667\u2013673","journal-title":"Mult Scler"},{"key":"1391_CR42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.exer.2018.02.010","volume":"170","author":"MC Sanchez-Migallon","year":"2018","unstructured":"Sanchez-Migallon MC et al (2018) Nerve fibre layer degeneration and retinal ganglion cell loss long term after optic nerve crush or transection in adult mice. Exp Eye Res 170:40\u201350","journal-title":"Exp Eye Res"},{"key":"1391_CR43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12974-017-0936-0","volume":"14","author":"SES Araujo","year":"2017","unstructured":"Araujo SES et al (2017) Inflammatory demyelination alters subcortical visual circuits. J Neuroinflammation 14:162","journal-title":"J Neuroinflammation"},{"key":"1391_CR44","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ana.26281","volume":"91","author":"A Bischof","year":"2022","unstructured":"Bischof A et al (2022) Spinal cord atrophy predicts progressive disease in relapsing multiple sclerosis. Ann Neurol 91:268\u2013281","journal-title":"Ann Neurol"},{"key":"1391_CR45","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/1352458508099479","volume":"15","author":"R Antulov","year":"2009","unstructured":"Antulov R et al (2009) Gender-related differences in MS: a study of conventional and nonconventional MRI measures. Mult Scler J 15:345\u2013354","journal-title":"Mult Scler J"},{"key":"1391_CR46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13293-020-00326-3","volume":"11","author":"RR Voskuhl","year":"2020","unstructured":"Voskuhl RR et al (2020) Sex differences in brain atrophy in multiple sclerosis. Biol Sex Differ 11:49","journal-title":"Biol Sex Differ"},{"key":"1391_CR47","doi-asserted-by":"publisher","DOI":"10.3791\/54348","author":"KS Evonuk","year":"2016","unstructured":"Evonuk KS, Moseley CE, Doyle RE, Weaver CT, DeSilva TM (2016) Determining immune system suppression versus CNS protection for pharmacological interventions in autoimmune demyelination. J Vis Exp. https:\/\/doi.org\/10.3791\/54348","journal-title":"J Vis Exp"},{"key":"1391_CR48","doi-asserted-by":"crossref","first-page":"e52658","DOI":"10.1371\/journal.pone.0052658","volume":"7","author":"AL Rowse","year":"2012","unstructured":"Rowse AL et al (2012) Lithium controls central nervous system autoimmunity through modulation of IFN-\u03b3 signaling. PLoS ONE 7:e52658\u2013e52658","journal-title":"PLoS ONE"},{"key":"1391_CR49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.exer.2011.12.011","volume":"96","author":"M Yu","year":"2012","unstructured":"Yu M et al (2012) Age-related changes in visual function in cystathionine-beta-synthase mutant mice, a model of hyperhomocysteinemia. Exp Eye Res 96:124\u2013131","journal-title":"Exp Eye Res"},{"key":"1391_CR50","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1017\/S0952523800012591","volume":"14","author":"NS Peachey","year":"1997","unstructured":"Peachey NS, Roveri L, Messing A, McCall MA (1997) Functional consequences of oncogene-induced horizontal cell degeneration in the retinas of transgenic mice. Vis Neurosci 14:627\u2013632","journal-title":"Vis Neurosci"},{"key":"1391_CR51","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.visres.2005.09.006","volume":"46","author":"WH Ridder","year":"2006","unstructured":"Ridder WH, Nusinowitz S (2006) The visual evoked potential in the mouse\u2014Origins and response characteristics. Vis Res 46:902\u2013913","journal-title":"Vis Res"},{"key":"1391_CR52","doi-asserted-by":"crossref","first-page":"eaax5936","DOI":"10.1126\/sciadv.aax5936","volume":"6","author":"KS Evonuk","year":"2020","unstructured":"Evonuk KS et al (2020) Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation. Sci Adv 6:eaax5936","journal-title":"Sci Adv"},{"key":"1391_CR53","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/hbm.22092","volume":"34","author":"MM Chakravarty","year":"2013","unstructured":"Chakravarty MM et al (2013) Performing label-fusion-based segmentation using multiple automatically generated templates. Hum Brain Mapp 34:2635\u20132654","journal-title":"Hum Brain Mapp"},{"key":"1391_CR54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuroimage.2005.09.041","volume":"30","author":"MM Chakravarty","year":"2006","unstructured":"Chakravarty MM, Bertrand G, Hodge CP, Sadikot AF, Collins DL (2006) The creation of a brain atlas for image guided neurosurgery using serial histological data. Neuroimage 30:359\u2013376","journal-title":"Neuroimage"}],"updated-by":[{"DOI":"10.1186\/s40478-022-01405-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T00:00:00Z","timestamp":1657843200000}}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01391-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01391-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01391-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T09:08:15Z","timestamp":1657876095000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01391-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1391"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01391-y","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s40478-022-01405-9","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s40478-022-01405-9","URL":"https:\/\/doi.org\/10.1186\/s40478-022-01405-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Robert Bermel discloses consultation for Astra Zeneca, Biogen, EMD Serono, Genzyme\/Sanofi, Genentech\/Roche, LabCorp, Novartis, TG Therapeutics, and VielaBio. Dr. Robert Bermel also discloses research support from Biogen, Genentech, and Novartis, and shares rights to intellectual property underlying the Multiple Sclerosis Performance Test, currently licensed to Qr8 Health and Biogen. Dr. Daniel Ontaneda discloses research support from Genentech, Genzyme, and Novartis and consulting fees from Biogen Idec, Genentech\/Roche, Genzyme, Janssen, Novartis, and Merck. Dr. Kunio Nakamura discloses personal compensation for licensing from Biogen and research support from Genzyme and Biogen. All other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}